Literature DB >> 15503327

Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?

Dirk Pauleit1, Karl-Josef Langen, Frank Floeth, Hubertus Hautzel, Markus J Riemenschneider, Guido Reifenberger, N Jon Shah, Hans-Wilhelm Müller.   

Abstract

PURPOSE: To determine whether the apparent diffusion coefficient (ADC) can be used to distinguish between tumor tissue and peritumoral brain tissue in cerebral gliomas.
MATERIALS AND METHODS: Twenty-two patients with 44 biopsies were enrolled in this study. ADC maps calculated from a diffusion-weighted (DW) multislice EPI sequence were coregistered with conventional MR images. Neuronavigated biopsies and intraoperative markers were used for correlation with the histologic specimens. ADC values and lesion-to-brain ratios of the different sequences were calculated and compared for tumor tissue and peritumoral brain tissue. A logistic regression analysis was performed to determine the diagnostic value of the ADC maps.
RESULTS: The ADC values and ratios demonstrated a large overlap between tumor tissue and peritumoral tissue. Group comparisons revealed a significantly (P=0.03) lower ADC ratio in tumor tissue (mean=1.28 +/- 0.39) compared to peritumoral tissue (mean=1.48 +/- 0.30), whereas the absolute ADC values did not differ significantly. In the logistic regression analysis, the lesion-to-brain ratio of the gadolinium (Gd)-enhanced T1-weighted sequence was the most valuable predictor of the presence of tumor tissue. The ADC value and ratio were not identified as significant predictors.
CONCLUSION: The ADC is not helpful for distinguishing tumor tissue from peritumoral brain tissue in gliomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503327     DOI: 10.1002/jmri.20177

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  25 in total

Review 1.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

2.  Apparent diffusion coefficient mapping in medulloblastoma predicts non-infiltrative surgical planes.

Authors:  Neena I Marupudi; Deniz Altinok; Luis Goncalves; Steven D Ham; Sandeep Sood
Journal:  Childs Nerv Syst       Date:  2016-07-12       Impact factor: 1.475

Review 3.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Authors:  Y Waerzeggers; R T Ullrich; P Monfared; T Viel; M Weckesser; W Stummer; O Schober; A Winkeler; A H Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 4.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

5.  Apparent diffusion coefficients for differentiation of cerebellar tumors in children.

Authors:  Z Rumboldt; D L A Camacho; D Lake; C T Welsh; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

6.  Diffusion MRI in the early diagnosis of malignant glioma.

Authors:  Joachim M Baehring; Wenya Linda Bi; Serguei Bannykh; Joseph M Piepmeier; Robert K Fulbright
Journal:  J Neurooncol       Date:  2006-10-07       Impact factor: 4.130

7.  Combined FET PET/ADC mapping: improved imaging of glioma infiltration?

Authors:  Karl-Josef Langen; Norbert Galldiks; Philipp Lohmann
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

8.  Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?

Authors:  Andrea Horváth; Gábor Perlaki; Arnold Tóth; Gergely Orsi; Szilvia Nagy; Tamás Dóczi; Zsolt Horváth; Péter Bogner
Journal:  J Neurooncol       Date:  2015-11-27       Impact factor: 4.130

Review 9.  Diffusion-weighted MRI in neuro-oncology.

Authors:  Joachim M Baehring; Robert K Fulbright
Journal:  CNS Oncol       Date:  2012-11

10.  Diagnostics of cerebral gliomas with radiolabeled amino acids.

Authors:  Karl-Josef Langen; Klaus Tatsch; Anca-Ligia Grosu; Andreas H Jacobs; Matthias Weckesser; Osama Sabri
Journal:  Dtsch Arztebl Int       Date:  2008-01-25       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.